Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance

INTRODUCTION: Chemotherapy remains the only available treatment for triple-negative (TN) breast cancer, and most patients exhibit an incomplete pathologic response. Half of patients exhibiting an incomplete pathologic response die within five years of treatment due to chemo-resistant, recurrent tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shenduo, Payne, Sturgis, Wang, Fang, Claus, Peter, Su, Zuowei, Groth, Jeffrey, Geradts, Joseph, de Ridder, Gustaaf, Alvarez, Rebeca, Marcom, Paul Kelly, Pizzo, Salvatore V., Bachelder, Robin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491247/
https://www.ncbi.nlm.nih.gov/pubmed/26141457
http://dx.doi.org/10.1186/s13058-015-0590-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491247/
https://www.ncbi.nlm.nih.gov/pubmed/26141457
http://dx.doi.org/10.1186/s13058-015-0590-3

Ejemplares similares